Showing results (371-380 of 539) with videos related to
Sort By:
Pageof 54
European Journal of Immunology|November 1, 1987
Inhibition by anti-HLA class II monoclonal antibodies of monocyte-dependent T cell proliferation induced by monoclonal antibody OKT3G Ruggiero, C Manzo, S Fontana, et al.Cellular Immunology|April 1, 1990
Inhibition by anti-HLA class I mAb of IL-2 and IL-2 receptor synthesis in lymphocytes stimulated with PHA-PM De Felice, M C Turco, F Costanzo, et al.Cancer Research|August 1, 1977
Approaches for the isolation of biologically functional tumor-associated antigensR A Reisfeld, G S David, S Ferrone, et al.Transplantation|July 1, 1976
Humoral sensitization in parous women: cytotoxic antibodies to non HL-A antigensS Ferrone, M R Mickey, P I Terasaki, et al.Pigment Cell Research|January 1, 1992
Modulation of the antigenic phenotype of human melanoma cells by differentiation-inducing and growth-suppressing agentsL Guarini, G M Graham, H Jiang, et al.Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1981
Tumor-associated antigens in spent medium of human melanoma cells: immunochemical characterization with xenoantiseraD R Galloway, R P McCabe, M A Pellegrino, et al.Pharmacology & Therapeutics|February 1, 1993
Human high molecular weight-melanoma associated antigen mimicry by mouse anti-idiotypic monoclonal antibodies MK2-23. Experimental studies and clinical trials in patients with malignant melanomaS Ferrone, Z J Chen, C C Liu, et al.Gastroenterologia Japonica|April 1, 1992
Soluble HLA class I antigens in sera of patients with chronic hepatitisK Sakaguchi, N Koide, T Takenami, et al.International Journal of Cancer|March 15, 1978
Establishment of paired tumor cells and autologous virus-transformed cell lines to define humoral immune responses in melanoma and sarcoma patientsR E Saxton, R F Irie, S Ferrone, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 1, 1995
Human high molecular weight-melanoma associated antigen mimicry by mouse anti-idiotypic monoclonal antibody MK2-23: modulation of the immunogenicity in patients with malignant melanomaA Mittelman, G Z Chen, G Y Wong, et al.Pageof 54